Credit: Recursion

Najat Khan, PhD profile page

Incoming CEO and President and current Chief R&D Officer and Chief Commercial Officer at Recursion

at Recursion

Dr. Najat Khan is an accomplished biopharma leader at the forefront of driving bold innovation to bring transformative therapies to patients. Building on a track record of integrating science, AI/data science and business leadership across both large pharma and emerging TechBio, she serves as chief research & development officer, chief commercial officer and board member at Recursion, where she is advancing an AI-native approach to discovering, developing and delivering novel medicines to address unmet patient needs.

Got a Question for Najat Khan, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Najat Khan, PhD

Total: 1

Industry Insight

Mapping Microglia To Unlock New Paths in Neuroscience

Dr. Najat Khan of Recursion shared insights into the creation of the Microglia Map and what it could mean for future drug discovery.